A Johnson & Johnson unit working to resolve massive cancer litigation in bankruptcy court was accused by a former head of the US Food and Drug Administration of making misleading claims that the ...
Janssen has sued Samsung Bioepis, alleging it violated a settlement agreement by authorizing an unauthorized Stelara® ...
Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best drug stocks to buy now.